Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive transfer of EBV specific T-cells for treatment of primary and rituxan resistant EBV lymphomas following allogeneic stem cell transplants (HSCT): Clinical, viral and immunologic corelates
    Meeting Abstract

    Doubrovina, E.; Oflaz-Sozmen, B.; Kernan, N. A.; Young, J.; Abramson, S.; Barker, J.; Boulad, F.; Castro-Malaspina, H.; Teruya-Feldstein, J.; Filippa, D.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Temporary licensing of hyporesponsive NK cells following allogeneic HCT is not affected by T-cells in the stem cell allograft
    Meeting Abstract

    Tarek, N.; Yu, J.; Venstrom, J. M.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • The Memorial Sloan-Kettering experience with allogeneic stem cell transplantation for T cell non-Hodgkins lymphomas
    Meeting Abstract

    Goldberg, J. D.; Chou, J.; Jakubowski, A. A.; Arcila, M. E.; Teruya-Feldstein, J.; Horwitz, S.; Barker, J. N.; Boulad, F.; Castro-Malaspina, H. R.; Hsu, K.; more...
    Biology of Blood and Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Phase II window of irinotecan plus carboplatin in newly diagnosed patients with rhandomyosarcoma: Results of Memorial Sloan-Kettering Cancer Center (MSKCC) Protocol IRB 03-099
    Meeting Abstract

    Wexler, L. H.; Wolden, S. L.; Abramson, S. J.; Price, A.; Karimi, S.; La Quaglia, M. P.; Chou, A. J.; Merola, P. R.; Meyers, P. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Mechanism of the antimyeloma activity of PU-H71, a novel purine scaffold HSP90 inhibitor
    Meeting Abstract

    Usmani, S. Z.; Bona, R. D.; Chiosis, G.; Li, Z.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Interim results of phase II trial of pegylated liposomal doxorubicin (PLD) followed by bexarotene in advanced cutaneous T-cell lymphoma (CTCL)
    Meeting Abstract

    Straus, D. J.; Duvic, M.; Horwitz, S. M.; Hymes, K. B.; Goy, A.; Hernandez-Ilizaliturri, F. J.; Feldman, T.; Wegner, B.; Myskowski, P.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Pralatrexate in patients with relapsed/refractory peripheral T-cell lymphoma (PTCL): Relationship between response and survival
    Meeting Abstract

    Shustov, A. R.; Pro, B.; Horwitz, S. M.; Jacobsen, E. D.; Boyd, A.; Fruchtman, S. M.; O'Connor, O.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Second-look operation with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma (RMS): A report from the Children's Oncology Group (COG)
    Meeting Abstract

    Rodeberg, D. A.; Wharam, M. D.; Lyden, E.; Stoner, J. A.; Brown, K. L.; Wolden, S. L.; Paidas, C. N.; Donaldson, S. S.; Hawkins, D. S.; Arndt, C. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • In vitro analysis of suicide gene expression and function in human T lymphocytes transduced to express a tumour-targeted chimeric antigen receptor
    Meeting Abstract

    Park, J. H.; Yeh, R.; Riviere, I.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I/II trial of clofarabine in patients with relapsed T-cell or NK-cell lymphomas
    Meeting Abstract

    Mulford, D. A.; Pohiman, B. L.; Hamlin, P. A.; Young, F.; Pamer, E.; Horwitz, S. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save